Amgen Inc. AMGN NASDAQ

Amgen Inc. (AMGN) reported total assets of $90.59B and total liabilities of $81.93B for quarter ending 2025-12-31, resulting in total equity of $8.66B.

The company held $9.13B in cash and short-term investments. Total debt stood at $54.6B, with net debt of $45.48B. The Debt-to-Equity (D/E) ratio was 6.31 (leveraged).

Current ratio is 1.14, suggesting adequate short-term liquidity. Interest coverage is 6x (adequate).

Criteria supported by this page:

• HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (81/100) — Total assets $90.59B and equity $8.66B support the company's competitive scale
• VALUE (33/100) — Debt-to-Equity 6.31 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 64/100 with 4/7 criteria passed.